[18F]DOPA remains the most-used radiotracer for human studies of dopamine biosynthesis, often in clinical studies combining it with measures of other aspects of dopaminergic nerve terminals (the DAT, VMAT2, dopamine receptors or perhaps drug-stimulated dopamine release) [13], and is now used in some clinical settings for the differential diagnosis of parkinsonism [14]. Here, SLC18A2 is linked to Parkinson disease.